OVP Venture Partners, the Kirkland, WA-based venture investor in IT, cleantech, and digital biology, said today it has recruited Irv Weissman to join its technical advisory group. Weissman, a professor at Stanford University, co-discovered stem cells that form blood in humans, and is a co-founder of three stem cell companies—SyStemix, StemCells, and Cellerant. He is the father of Carl Weissman, a managing director with OVP and CEO of Seattle-based Accelerator.
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
